Cargando…

White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts

INTRODUCTION: White matter hyperintensities (WMHs) are common magnetic resonance imaging (MRI) findings in the aging population in general, as well as in patients with neurodegenerative diseases. They are known to exacerbate the cognitive deficits and worsen the clinical outcomes in the patients. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Dadar, Mahsa, Mahmoud, Sawsan, Zhernovaia, Maryna, Camicioli, Richard, Maranzano, Josefina, Duchesne, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668605/
https://www.ncbi.nlm.nih.gov/pubmed/36155321
http://dx.doi.org/10.1016/j.nicl.2022.103204
_version_ 1784831950395015168
author Dadar, Mahsa
Mahmoud, Sawsan
Zhernovaia, Maryna
Camicioli, Richard
Maranzano, Josefina
Duchesne, Simon
author_facet Dadar, Mahsa
Mahmoud, Sawsan
Zhernovaia, Maryna
Camicioli, Richard
Maranzano, Josefina
Duchesne, Simon
author_sort Dadar, Mahsa
collection PubMed
description INTRODUCTION: White matter hyperintensities (WMHs) are common magnetic resonance imaging (MRI) findings in the aging population in general, as well as in patients with neurodegenerative diseases. They are known to exacerbate the cognitive deficits and worsen the clinical outcomes in the patients. However, it is not well-understood whether there are disease-specific differences in prevalence and distribution of WMHs in different neurodegenerative disorders. METHODS: Data included 976 participants with cross-sectional T1-weighted and fluid attenuated inversion recovery (FLAIR) MRIs from the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) cohort of the Canadian Consortium on Neurodegeneration in Aging (CCNA) with eleven distinct diagnostic groups: cognitively intact elderly (CIE), subjective cognitive impairment (SCI), mild cognitive impairment (MCI), vascular MCI (V-MCI), Alzheimer’s dementia (AD), vascular AD (V-AD), frontotemporal dementia (FTD), Lewy body dementia (LBD), cognitively intact elderly with Parkinson’s disease (PD-CIE), cognitively impaired Parkinson’s disease (PD-CI), and mixed dementias. WMHs were segmented using a previously validated automated technique. WMH volumes in each lobe and hemisphere were compared against matched CIE individuals, as well as each other, and between men and women. RESULTS: All cognitively impaired diagnostic groups had significantly greater overall WMH volumes than the CIE group. Vascular groups (i.e. V-MCI, V-AD, and mixed dementia) had significantly greater WMH volumes than all other groups, except for FTD, which also had significantly greater WMH volumes than all non-vascular groups. Women tended to have lower WMH burden than men in most groups and regions, controlling for age. The left frontal lobe tended to have a lower WMH burden than the right in all groups. In contrast, the right occipital lobe tended to have greater WMH volumes than the left. CONCLUSIONS: There were distinct differences in WMH prevalence and distribution across diagnostic groups, sexes, and in terms of asymmetry. WMH burden was significantly greater in all neurodegenerative dementia groups, likely encompassing areas exclusively impacted by neurodegeneration as well as areas related to cerebrovascular disease pathology.
format Online
Article
Text
id pubmed-9668605
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96686052022-11-17 White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts Dadar, Mahsa Mahmoud, Sawsan Zhernovaia, Maryna Camicioli, Richard Maranzano, Josefina Duchesne, Simon Neuroimage Clin Regular Article INTRODUCTION: White matter hyperintensities (WMHs) are common magnetic resonance imaging (MRI) findings in the aging population in general, as well as in patients with neurodegenerative diseases. They are known to exacerbate the cognitive deficits and worsen the clinical outcomes in the patients. However, it is not well-understood whether there are disease-specific differences in prevalence and distribution of WMHs in different neurodegenerative disorders. METHODS: Data included 976 participants with cross-sectional T1-weighted and fluid attenuated inversion recovery (FLAIR) MRIs from the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) cohort of the Canadian Consortium on Neurodegeneration in Aging (CCNA) with eleven distinct diagnostic groups: cognitively intact elderly (CIE), subjective cognitive impairment (SCI), mild cognitive impairment (MCI), vascular MCI (V-MCI), Alzheimer’s dementia (AD), vascular AD (V-AD), frontotemporal dementia (FTD), Lewy body dementia (LBD), cognitively intact elderly with Parkinson’s disease (PD-CIE), cognitively impaired Parkinson’s disease (PD-CI), and mixed dementias. WMHs were segmented using a previously validated automated technique. WMH volumes in each lobe and hemisphere were compared against matched CIE individuals, as well as each other, and between men and women. RESULTS: All cognitively impaired diagnostic groups had significantly greater overall WMH volumes than the CIE group. Vascular groups (i.e. V-MCI, V-AD, and mixed dementia) had significantly greater WMH volumes than all other groups, except for FTD, which also had significantly greater WMH volumes than all non-vascular groups. Women tended to have lower WMH burden than men in most groups and regions, controlling for age. The left frontal lobe tended to have a lower WMH burden than the right in all groups. In contrast, the right occipital lobe tended to have greater WMH volumes than the left. CONCLUSIONS: There were distinct differences in WMH prevalence and distribution across diagnostic groups, sexes, and in terms of asymmetry. WMH burden was significantly greater in all neurodegenerative dementia groups, likely encompassing areas exclusively impacted by neurodegeneration as well as areas related to cerebrovascular disease pathology. Elsevier 2022-09-16 /pmc/articles/PMC9668605/ /pubmed/36155321 http://dx.doi.org/10.1016/j.nicl.2022.103204 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Regular Article
Dadar, Mahsa
Mahmoud, Sawsan
Zhernovaia, Maryna
Camicioli, Richard
Maranzano, Josefina
Duchesne, Simon
White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
title White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
title_full White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
title_fullStr White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
title_full_unstemmed White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
title_short White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
title_sort white matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668605/
https://www.ncbi.nlm.nih.gov/pubmed/36155321
http://dx.doi.org/10.1016/j.nicl.2022.103204
work_keys_str_mv AT dadarmahsa whitematterhyperintensitydistributiondifferencesinagingandneurodegenerativediseasecohorts
AT mahmoudsawsan whitematterhyperintensitydistributiondifferencesinagingandneurodegenerativediseasecohorts
AT zhernovaiamaryna whitematterhyperintensitydistributiondifferencesinagingandneurodegenerativediseasecohorts
AT camiciolirichard whitematterhyperintensitydistributiondifferencesinagingandneurodegenerativediseasecohorts
AT maranzanojosefina whitematterhyperintensitydistributiondifferencesinagingandneurodegenerativediseasecohorts
AT duchesnesimon whitematterhyperintensitydistributiondifferencesinagingandneurodegenerativediseasecohorts
AT whitematterhyperintensitydistributiondifferencesinagingandneurodegenerativediseasecohorts